A Study Evaluating the Safety of the Nasal Pump

Oyster Point Pharma

Status and phase: Terminated; Phase 4

Conditions: Dry Eye; Kerato Conjunctivitis Sicca

Treatments: Drug: Tyrvaya Nasal Pump

Study type: Interventional

Funder types: Industry

Identifiers

NCT06329687

OPP-010

Details and patient eligibility

About

The objective of this study is to determine the safety of the Tyrvaya nasal pump.

Full description

The study is testing the hypothesis that the use of the Tyrvaya nasal pump with silicone lubricant does not introduce any additional safety concerns as compared to the safety of the Tyrvaya nasal pump without the additional silicone lubricant.

Enrollment: 5 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Be at least 18 years of age
• Have provided verbal and written informed consent
• Willing to comply with all study related visits and procedures

Exclusion criteria

• Be currently enrolled in an investigational drug or device study or have used an investigational drug or device within 30 days prior to Visit 1.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

5 participants in 1 patient group

Nasal Pump

Experimental group

Description:

Tyrvaya nasal pump with additional silicone lubricant

Treatment:

Drug: Tyrvaya Nasal Pump